1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Energy division restructuring

Discussion in 'Olympus' started by anonymous, Dec 19, 2018 at 7:12 PM.

  1. anonymous

    anonymous Guest

    Yeah, we'll see,. Get to work boys spinning your wheels. HPG accounts are going to get a boat-load of your time and free product....and then stay with J&J due to aggregate spend benefits. At least your SFA activity sheet will be full. Have fun clowns.
     
  2. anonymous

    anonymous Guest